Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Microparticles facilitate neutrophil/platelet crosstalk.

Andrews RK, Berndt MC.

Blood. 2008 Sep 15;112(6):2174-5. doi: 10.1182/blood-2008-06-163063. No abstract available.

PMID:
18779396
2.

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, ten Cate H, Leyte A, Terpstra WE, Falanga A.

Haematologica. 2009 Jul;94(7):911-8. doi: 10.3324/haematol.13774. Epub 2009 Jun 8.

3.

Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes.

Messer L, Alsaleh G, Freyssinet JM, Zobairi F, Leray I, Gottenberg JE, Sibilia J, Toti-Orfanoudakis F, Wachsmann D.

Arthritis Res Ther. 2009;11(2):R40. doi: 10.1186/ar2648. Epub 2009 Mar 16.

4.

Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formation.

Dunkel B, Rickards KJ, Werling D, Page CP, Cunningham FM.

Vet Immunol Immunopathol. 2009 Sep 15;131(1-2):25-32. doi: 10.1016/j.vetimm.2009.03.004. Epub 2009 Mar 20.

PMID:
19362377
5.

Cell-derived microparticles in haemostasis and vascular medicine.

Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A.

Thromb Haemost. 2009 Mar;101(3):439-51. Review.

PMID:
19277403
6.

Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury.

Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H.

Ann Surg. 2009 Nov;250(5):783-90. doi: 10.1097/SLA.0b013e3181bd95b7.

PMID:
19806052
7.

Microparticles, thrombosis and cancer.

Aharon A, Brenner B.

Best Pract Res Clin Haematol. 2009 Mar;22(1):61-9. doi: 10.1016/j.beha.2008.11.002. Review.

PMID:
19285273
8.

Radiofrequency catheter ablation of atrial flutter induces the release of platelet and leukocyte-derived procoagulant microparticles and a prothrombotic state.

Jesel L, Morel O, Pynn S, Radulescu B, Grunebaum L, Freyssinet JM, Ohlmann P, Bareiss P, Toti F, Chauvin M.

Pacing Clin Electrophysiol. 2009 Feb;32(2):193-200. doi: 10.1111/j.1540-8159.2008.02202.x.

PMID:
19170908
9.

Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis.

Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K, Kishimoto S.

Clin Immunol. 2009 Jun;131(3):495-500. doi: 10.1016/j.clim.2009.01.006. Epub 2009 Feb 13.

PMID:
19217350
10.

Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans.

Wang JM, Yang Z, Xu MG, Chen L, Wang Y, Su C, Tao J.

Eur J Pharmacol. 2009 Jul 1;614(1-3):77-83. doi: 10.1016/j.ejphar.2009.04.037. Epub 2009 May 3.

PMID:
19401197
11.

Ordering of solid microparticles at liquid crystal-water interfaces.

Lin IH, Koenig GM Jr, de Pablo JJ, Abbott NL.

J Phys Chem B. 2008 Dec 25;112(51):16552-8. doi: 10.1021/jp807286s.

PMID:
19049270
12.

Microparticles and thrombotic disease.

Davizon P, López JA.

Curr Opin Hematol. 2009 Sep;16(5):334-41. doi: 10.1097/MOH.0b013e32832ea49c. Review.

PMID:
19606028
13.

Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.

Maghsoodi M, Esfahani M.

Pharm Dev Technol. 2009;14(4):442-50. doi: 10.1080/10837450902748404.

PMID:
19235551
14.

Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore.

Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J.

Lab Invest. 2009 Apr;89(4):374-84. doi: 10.1038/labinvest.2009.13. Epub 2009 Feb 23.

15.

Controlled delivery of bovine serum albumin from carboxymethyl xanthan microparticles.

Maiti S, Ray S, Sa B.

Pharm Dev Technol. 2009;14(2):165-72.

PMID:
19562833
16.

Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.

Kendall RA, Alhnan MA, Nilkumhang S, Murdan S, Basit AW.

Eur J Pharm Sci. 2009 Jun 28;37(3-4):284-90. doi: 10.1016/j.ejps.2009.02.015. Epub 2009 Mar 6.

PMID:
19491017
17.

Circulating microparticles, lupus anticoagulant and recurrent miscarriages.

Alijotas-Reig J, Palacio-Garcia C, Vilardell-Tarres M.

Eur J Obstet Gynecol Reprod Biol. 2009 Jul;145(1):22-6. doi: 10.1016/j.ejogrb.2009.04.002. Epub 2009 May 2. Review.

PMID:
19410360
18.

Surface engineering of microparticles by novel protein transfer for targeted antigen/drug delivery.

Bumgarner GW, Shashidharamurthy R, Nagarajan S, D'Souza MJ, Selvaraj P.

J Control Release. 2009 Jul 20;137(2):90-7. doi: 10.1016/j.jconrel.2009.03.011. Epub 2009 Mar 26.

PMID:
19328830
19.

The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.

Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M.

Biomaterials. 2009 May;30(13):2440-8. doi: 10.1016/j.biomaterials.2009.01.019. Epub 2009 Feb 12.

PMID:
19215978
20.

Development of highly porous large PLGA microparticles for pulmonary drug delivery.

Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y.

Biomaterials. 2009 Apr;30(10):1947-53. doi: 10.1016/j.biomaterials.2008.12.044. Epub 2009 Jan 8.

PMID:
19135245

Supplemental Content

Support Center